VACDIVA (2019–2024) focused on developing a safe DIVA vaccine and associated diagnostic tests for ASF control and eradication in both wild boar and domestic pig populations.
ALLATORVOSTUDOMANYI KUTATOINTEZET
Hungarian veterinary research institute specialising in African Swine Fever vaccines, DIVA diagnostics, and fish welfare in recirculated aquaculture systems.
Their core work
The Veterinary Medical Research Institute in Budapest is a Hungarian public research centre specialising in animal health across both terrestrial and aquatic species. Their work covers disease diagnostics, vaccine development, and welfare assessment — not abstract laboratory science but applied veterinary tools designed to solve real agricultural problems. In the swine sector they contributed to the development and validation of DIVA (Differentiating Infected from Vaccinated Animals) diagnostic strategies for African Swine Fever, one of the most economically damaging livestock diseases in Europe. More recently they expanded into aquaculture, bringing veterinary expertise to recirculated fish production systems — covering fish welfare, microbial ecology, and sensory quality analysis.
What they specialise in
VACDIVA required epidemiological modelling and field-applicable control strategies alongside the laboratory vaccine work, suggesting applied expertise beyond bench science.
RASOPTA (2021–2025) addresses welfare, flavour quality, and microbial ecology in recirculated aquaculture systems, extending the institute's animal health competencies into the aquatic domain.
RASOPTA keywords include microbial ecology and water treatment, indicating methodological capability in characterising microbial communities within closed aquaculture environments.
RASOPTA lists DNA-chip among its core technologies, pointing to molecular profiling capacity applicable to both animal welfare monitoring and pathogen detection.
How they've shifted over time
Their H2020 entry in 2019 was firmly in swine disease territory — African Swine Fever vaccines, DIVA testing, and epidemiological control — reflecting the acute European crisis in pig farming at that time. By 2021 their focus shifted entirely to aquaculture, specifically recirculated fish production systems, fish welfare assessment, sensory quality, and microbial water analysis. This pivot from pig disease to fish aquaculture is not a contradiction for a veterinary institute — it reflects a deliberate broadening of species scope — but it does suggest the institute is repositioning itself as an animal health competence centre across production sectors rather than a swine-only specialist.
The institute appears to be building a cross-species veterinary research portfolio, making them a viable partner for any food production consortium that needs animal health or welfare expertise — whether in livestock or aquaculture.
How they like to work
The institute has participated exclusively as a consortium partner, never as a project coordinator, in both of its H2020 projects. This is consistent with a specialist research institute that brings deep domain expertise to larger consortia rather than driving programme management. The breadth of their network — 30 unique partners across 17 countries from just two projects — indicates they join well-connected, multi-national consortia and are likely valued for specific technical contributions rather than administrative leadership.
Despite only two projects, the institute has engaged with 30 distinct partner organisations across 17 countries — an unusually broad exposure for such a small H2020 footprint. Their network is pan-European in character, consistent with large Innovation Action and MSCA training network consortia.
What sets them apart
Few research institutes combine validated expertise in African Swine Fever — still an active threat to European pig farming — with emerging capability in recirculated aquaculture systems and fish welfare. For a consortium needing credible veterinary input on animal health, welfare, or diagnostic tool validation across production species, this institute offers a rare dual-sector profile within one Hungarian institution. Their involvement in an MSCA training network (RASOPTA) also signals capacity to host researchers, which adds value to partnerships with a training or mobility component.
Highlights from their portfolio
- VACDIVADirectly addresses African Swine Fever — the highest-priority animal disease threat in Europe — with a focus on the technically demanding DIVA vaccine strategy that allows vaccinated animals to be distinguished from infected ones, a critical requirement for regulatory approval.
- RASOPTAThe institute's largest grant (EUR 229,715) and its entry into aquaculture via an MSCA Innovative Training Network, which combines fish welfare research with sensory quality and microbial ecology in a format that funds early-stage researcher training.